The statistical challenge of false positives with microarrays;Défis statistiques posés par les biopuces: Autant d'espoir que de faux positifs?

Medecine/Sciences

Volumn 24, Issue 3, 2008, Pages 317-319

  Michiels, Stefan ^a   Hill, Catherine ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FALSE POSITIVE RESULT; GENE IDENTIFICATION; HUMAN; MICROARRAY ANALYSIS; PROGNOSIS; SHORT SURVEY; STATISTICAL ANALYSIS;

EID: 41149173671     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2008243317     Document Type: Short Survey

References (12)

1. Jordan B. Chroniques génomiques. Des puces ADN en clinique ? Med Sci (Paris) 2007 ; 23 : 210-4.
2. Figarella-Branger D, Colin C, Chinot O, et al. Tumorothèque de l'AP-HM : cartographie moléculaire des gliomes. Med Sci (Paris) 2006 ; 22 (suppl 1) : 54-9.
3. Jardin F, Tilly H. Un saut (de puce) vers une application clinique des profils d'expression génique dans les lymphomes. Med Sci (Paris) 2004 ; 20 : 848-50.
4. Rothwell PM. Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet 2005 ; 365 : 176-86.
5. Michiels S, Koscielny S, Hill C. Interpretation of microarray data in cancer. Br J Cancer 2007 ; 96 : 1155-8.
6. Van 't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002 ; 415 : 530-6.
7. Pawitan Y, Michiels S, Koscielny S, et al. False discovery rate, sensitivity and sample size for microarray studies. Bioinformatics 2005 ; 21 : 3017-24.
8. Michiels S, Koscielny S, Hill C. Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 2005 ; 365 : 488-92.
9. Ein-Dor L, Zuk O, Domany E. Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. Proc Natl Acad Sci USA 2006 ; 103 : 5923-8.
10. Ransohoff DF. Bias as a threat to the validity of cancer molecular-marker research. Nat Rev Cancer 2005 ; 5 : 142-9.
11. Van de Vijver MJ, He YD, van't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002 ; 347 : 1999-2009.
12. Buyse M, Loi S, van't Veer L, et al. Transbig consortium. Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst 2006 ; 98 : 1183-92.